Sunday, October 25, 2026Daily EditionIndependent journalism
BeCrypto NewsIndependent digital asset reporting
Sign in Write
BTC $80,492 +0.01%ETH $2,348.42 +0.23%SOL $101.69 +0.29%XRP $1.30 +0.51%BNB $741.53 +1.43%DOGE $0.0772 −0.07%Prices: CoinGecko,
Back
Markets

Genmab and Incyte Plan Phase 1/2 Trial for KRAS-Mutated Metastatic Colorectal Cancer

By John Kim for TokenPost

Image: TokenPost

The study will combine petosemtamab and INCB161734 with chemotherapy as a potential first-line treatment.

Read the full story on TokenPost

BeCrypto News shows a short excerpt and links to the publisher. The full report belongs to TokenPost.

Latest in Markets

All Markets stories